Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$12.5M
+11.4% from 2023
Prescriptions
4,467
$2,809.43 per claim
Patients
929
904 prescribers
Total spending, 2024
$12.5M
$13,508.85 per patient
Medicare prescription drug plans paid $12.5M for Teflaro in 2024, for 4,467 prescriptions and refills to 929 patients (up 11.4% from 2023). The average cost per claim was $2,809.43.
Florida had the highest Medicare cost for Teflaro in 2024: $1.5M for 535 claims, followed by New York ($1.1M).
Varun Phadke, infectious disease in Atlanta, GA, had the highest Medicare cost for Teflaro in 2024: 53 claims costing $177K.
Teflaro is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Allergan Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Varun Phadke Atlanta, GA | Infectious Disease | 53 | Under 11 | $177K |
| Helen Jahna Rochester, NY | Nurse Practitioner | 29 | Under 11 | $142K |
| Poppy Markwell |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 879 | 4,054 | 965 | $11.3M |
| 2023 | 836 | 3,876 | 887 | $11.3M |
| 2024 | 904 | 4,467 | 929 | $12.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 78 |
| Under 11 |
| $138K |
| Ndidiamaka U Obiesie Phoenix, AZ | Infectious Disease | 29 | Under 11 | $105K |
| Courtney Nichols Columbus, OH | Infectious Disease | 30 | Under 11 | $100K |
| Daylee S Sheppard Gainesville, FL | Physician Assistant | 31 | Under 11 | $98K |
| Colleen M Burgoyne Rochester, NY | Nurse Practitioner | 19 | Under 11 | $91K |
| James E Everhart Greenville, SC | Infectious Disease | 17 | Under 11 | $88K |
| Michael P McCarthy Baton Rouge, LA | Pulmonary Disease | 24 | Under 11 | $80K |
| Heather C Michael Charlotte, NC | Infectious Disease | 18 | Under 11 | $80K |
| Stephen C Threlkeld Memphis, TN | Infectious Disease | 35 | Under 11 | $77K |
| Ephraim B Gammada Winchester, TN | Internal Medicine | 60 | Under 11 | $74K |
| Daniel J Minter San Francisco, CA | Infectious Disease | 22 | Under 11 | $70K |
| Jeniffer Torres-Velazco Tampa, FL | Infectious Disease | 13 | Under 11 | $68K |
| Dima Youssef Johnson City, TN | Infectious Disease | 20 | Under 11 | $68K |
| Jad A Khoury Saint Louis, MO | Infectious Disease | 20 | Under 11 | $65K |
| Lindsi D Pizzolato Lafayette, LA | Nurse Practitioner | 27 | Under 11 | $64K |
| Ali A Hassoun Huntsville, AL | Infectious Disease | 26 | Under 11 | $58K |
| Abby I Huang Sellersville, PA | Infectious Disease | 15 | Under 11 | $58K |
| Ameera W Siddiqi Fayetteville, GA | Infectious Disease | 17 | Under 11 | $55K |
| James D Danner Altavista, VA | Family Practice | 16 | Under 11 | $54K |
| Pauline Ho Placentia, CA | Infectious Disease | 15 | Under 11 | $54K |
| Marcus G Tomberlin Vancouver, WA | Infectious Disease | 24 | Under 11 | $53K |
| Eugene N Knight Miami, FL | Nurse Practitioner | 12 | Under 11 | $52K |
| Darrell R Pietsch Waco, TX | Family Practice | 19 | Under 11 | $51K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Allergan Inc. ABBV | 4,467 | $12.5M |